Oppenheimer analyst Brian Schwartz raised the firm’s price target on Agilysys (AGYS) to $135 from $120 and keeps an Outperform rating on the shares. While the firm isn’t updating its forecast, its confidence is increasing that Q3 and FY2025 consensus estimates are achievable, and that Agilysys will be a good fundamentals growth compounder.